|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| C07D 487/04 | (2006.01) | ||
| C07D 498/04 | (2006.01) | ||
| A61K 31/553 | (2006.01) |
| (11) | Number of the document | 3886991 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20834024.0 |
| Date of filing the European patent application | 2020-12-04 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-21 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (86) | Number | PCT/US2020/063272 |
| Date | 2020-12-04 |
| (87) | Number | WO 2021/118877 |
| Date | 2021-06-17 |
| (30) | Number | Date | Country code |
| 201962946586 P | 2019-12-11 | US |
| (72) |
BOULET, Serge Louis , US
FORTNER, Kevin Charles , US
GUO, Deqi , US
HYMAN, David Michael , US
PENG, Sheng-Bin , US
SI, Chong , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | KRas G12C slopikliai |
| KRAS G12C INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-11-19 | 6 | 139.00 EUR |
| 2026-12-04 |